Mesenchymal stem/stromal cells from human pluripotent stem cell-derived brain organoid enhance the ex vivo expansion and maintenance of hematopoietic stem/progenitor cells.

Authors:
Zhou Y; Cai X; Zhang X; Dong Y; Pan X and 8 more

Journal:
Stem Cell Res Ther

Publication Year: 2024

DOI:
10.1186/s13287-023-03624-w

PMCID:
PMC10916050

PMID:
38443990

Journal Information

Journal Title: Stem Cell Res Ther

Detailed journal information not available.

Publication Details

Subject Category: Medicine, Research & Experimental

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"availability of data and materials the data discussed in this publication have been deposited in ncbi's gene expression omnibus and are accessible through geo series accession number gse220781. availability of data and materials the data discussed in this publication have been deposited in ncbi's gene expression omnibus and are accessible through geo series accession number gse220781"

Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis research does not contain clinical experiments. All the experiments are approved under the project of “Identification the role and mechanism of mesenchymal stem cells isolated from human brain-specific organoids in human hematopoiesis” by the institutional ethics review committee of Institute of Blood Transfusion, Chinese Academy of Medical Sciences, China. The approval number is 202030. The use of the human umbilical cord tissue from a healthy donor. Written informed consent was obtained from the pregnant women before labor. The approval date for these animal experiments and the use of human umbilical cord-derived MSCs is 2020-09-16. Our manuscript is reported following the ARRIVE guidelines. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This work was supported by the National Natural Science Foundation of China (82170121, awarded to F.M.; 82000119, awarded to Y.Z.), the CAMS Initiatives for Innovative Medicine (2021-I2M-1-060, awarded to J.X.L) and the Sichuan Science and Technology Program (2023NSFSC1705, awarded to Y.Z.)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025